SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12171909
Source:
http://linkedlifedata.com/resource/pubmed/id/12171909
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006826
,
umls-concept:C0026764
,
umls-concept:C0032105
,
umls-concept:C0039736
,
umls-concept:C0086045
,
umls-concept:C0172367
,
umls-concept:C0205329
,
umls-concept:C0332281
,
umls-concept:C0380603
,
umls-concept:C0871261
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2911692
pubmed:issue
8
pubmed:dateCreated
2002-8-12
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12171909-11555579
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2
,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...
,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines
,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1078-0432
pubmed:author
pubmed-author:GoRonald SRS
,
pubmed-author:HorstmanAndrew LAL
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2750; author reply 2751
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12171909-Angiogenesis Inhibitors
,
pubmed-meshheading:12171909-Disease Progression
,
pubmed-meshheading:12171909-Endothelial Growth Factors
,
pubmed-meshheading:12171909-Fibroblast Growth Factor 2
,
pubmed-meshheading:12171909-Humans
,
pubmed-meshheading:12171909-Intercellular Signaling Peptides and Proteins
,
pubmed-meshheading:12171909-Lymphokines
,
pubmed-meshheading:12171909-Multiple Myeloma
,
pubmed-meshheading:12171909-Thalidomide
,
pubmed-meshheading:12171909-Vascular Endothelial Growth Factor A
,
pubmed-meshheading:12171909-Vascular Endothelial Growth Factors
pubmed:year
2002
pubmed:articleTitle
Correspondence re: K. Neben et al., high plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001.
pubmed:publicationType
Letter
,
Comment